Susan G. Komen for the Cure®, the world's largest breast cancer organization, awarded more than $100 million in research grants last year, representing the largest single-year investment in research in the organization's 26-year history and a 30 percent increase over the previous year’s award total of $77 million. The 2008 grants slate moves Komen for the Cure closer to accomplishing its goal of investing another $2 billion in breast cancer research and community health programs by 2017.
Any not-for-profit organization that provides breast health and/or breast cancer education, screening, or treatment services may apply for a grant.
Grants for breast health education, breast cancer screening, diagnosis and treatment support programs are provided by Komen Affiliates with funds raised through events such as the Komen Race for the Cure®.
Komen Affiliates award grants only to other non-profit organizations, educational institutions and government entities within their defined service areas.
In order to ensure the funds raised make the greatest impact, Komen Affiliates work with local medical experts and community leaders to conduct comprehensive community needs assessments. These community profiles are then used to establish local grant application and review processes consistent with the Komen organization's standards and mission.
Programs funded from affiliate fund-raising events range from educating women about healthy behaviors and early detection to providing treatment services to women and men who are low income/uninsured. The affiliate empowers women to take charge of their own health through participation in breast health seminars and outreach support targeting underserved and hard to reach populations.
Up to 75 percent of the net proceeds from the Acadiana Affiliate fund-raising events stay in our six parish service area to fund low and no-cost mammograms, education on the importance of monthly breast self-exams and early detection, and access to diagnostic equipment and procedures. The remaining 25 percent of the net proceeds support the Komen National Research Grant Program, which funds groundbreaking breast cancer research.